Holen Sie sich die Stockscreener-App
1.3034
0.39%
0.0134
Schlusskurs vom Vortag:
$1.29
Offen:
$1.3
24-Stunden-Volumen:
1.10M
Relative Volume:
1.64
Marktkapitalisierung:
$130.02M
Einnahmen:
$31.20M
Nettoeinkommen (Verlust:
$-21.68M
KGV:
-5.3374
EPS:
-0.2442
Netto-Cashflow:
$-15.52M
1W Leistung:
-13.67%
1M Leistung:
-22.92%
6M Leistung:
-48.81%
1J Leistung:
-42.44%
1-Tages-Spanne:
$1.29
$1.36
1-Wochen-Bereich:
$1.28
$1.51
52-Wochen-Spanne:
$1.28
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Firmenname
Stereotaxis Inc
Sektor
Telefon
314-678-6100
Adresse
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
1.305 | 128.52M | 31.20M | -21.68M | -15.52M | -0.2442 |
ISRG
Intuitive Surgical Inc
|
356.79 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
159.32 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.95 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.38 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.16 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-01-10 | Eingeleitet | ROTH MKM | Buy |
| 2022-07-12 | Eingeleitet | Aegis Capital | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2022-01-05 | Eingeleitet | Craig Hallum | Buy |
| 2022-01-05 | Eingeleitet | Loop Capital | Buy |
| 2021-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-08 | Eingeleitet | Northland Capital | Outperform |
| 2020-04-09 | Eingeleitet | Cowen | Outperform |
| 2020-04-07 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Stereotaxis Inc Aktie (STXS) Neueste Nachrichten
Stereotaxis Inc (STXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stereotaxis Inc (STXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Stereotaxis Inc (STXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stereotaxis Inc (STXS) Balance Sheet - TradingKey
Stereotaxis, Inc. Revenue Breakdown – AMEX:STXS - TradingView
Stereotaxis Inc. (STXS) Stock Price | Live Quotes & Charts | AMEX - timothysykes.com
Stereotaxis Inc (STXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stereotaxis, Inc. (STXS) stock price, news, quote and history - Yahoo Finance UK
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026 - The Manila Times
Stereotaxis to Discuss Robotic Intervention Results on Aug. 11 - Stock Titan
Stereotaxis, Inc. opens new robotic EP laboratory in Hungary - Traders Union
University of Szeged Pioneers First Robotic Cardiology Program in Hungary - GlobeNewswire
University of Szeged Treats First Patients With Genesis System - Stock Titan
Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings - Yahoo Finance
STXS Slides As Stereotaxis Clears Massive Secondary Share Block - timothysykes.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Stereotaxis Faces Integration, Financial, and Regulatory Challenges Following Robocath Acquisition - Minichart
Stereotaxis completes acquisition of Robocath; issues 6.27M shares, up to $25M earnout possible - TradingView
Stereotaxis (NYSE American: STXS) flags Robocath earnouts and 19.9% dilution - Stock Titan
Stereotaxis Files Resale Registration for Up to 108.9 Million Shares - Moomoo
Form S-3 Stereotaxis Inc For: 15 July By Investing.com - Investing.com Nigeria
Stereotaxis Finalizes Robocath Acquisition - dicardiology.com
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView
Stereotaxis closes Robocath takeover - MedTech Dive
Stereotaxis completes acquisition of Robocath By Investing.com - Investing.com India
Stereotaxis, Inc. completes Robocath acquisition to accelerate endovascular robotics expansion - Traders Union
Stereotaxis Closes $45M Deal for Robocath - Medical Product Outsourcing
Stereotaxis completes acquisition of Robocath - Investing.com
Robocath deal adds stock, warrants and earnouts at Stereotaxis (STXS) - Stock Titan
Stereotaxis Completes Acquisition of Robocath - GlobeNewswire
Stereotaxis folds Robocath into its surgical robotics platform - Stock Titan
Enterprise value to revenue forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Price to sales forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Enterprise value to EBITDA forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView
Stereotaxis, Inc. completed the acquisition of Robocath SAS. - marketscreener.com
Enterprise value to EBITDA forward of Stereotaxis, Inc. – LS:A1J09L - TradingView
Price to book forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan
Director at Stereotaxis (STXS) receives 43,103-share equity grant - Stock Titan
Stereotaxis (STXS) director awarded 43,103 restricted share units, holding 1,035,560 shares - Stock Titan
Robotics redefine electrophysiology, Stereotaxis, Inc. explores in latest podcast - Traders Union
STXS Q1 2026 Earnings: EPS Misses Estimates as Stock SlipsWeak Earnings Momentum - dars.gov.et
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) - Yahoo Finance
Stereotaxis Inc. (STXS) Holds Near Support Amidst Low VolatilityMomentum Stock Picks - dars.gov.et
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2000 Value Benchmark - marketscreener.com
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Price to earnings forward of Stereotaxis, Inc. – AMEX:STXS - TradingView
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 3000 Value Benchmark - marketscreener.com
STXSStereotaxis Inc Options - Finviz
Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2500 Value Benchmark - marketscreener.com
Stereotaxis, Inc. Hits New 52-Week Low at $1.60 Amid Decline - MarketsMojo
Finanzdaten der Stereotaxis Inc-Aktie (STXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
4.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):